Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Coeptis Therapeutics Holdings (COEP) Operating Leases (2022 - 2025)

Historic Operating Leases for Coeptis Therapeutics Holdings (COEP) over the last 4 years, with Q3 2025 value amounting to $29865.0.

  • Coeptis Therapeutics Holdings' Operating Leases fell 5797.75% to $29865.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $29865.0, marking a year-over-year decrease of 5797.75%. This contributed to the annual value of $61180.0 for FY2024, which is 3834.28% down from last year.
  • According to the latest figures from Q3 2025, Coeptis Therapeutics Holdings' Operating Leases is $29865.0, which was down 5797.75% from $40612.0 recorded in Q2 2025.
  • Coeptis Therapeutics Holdings' 5-year Operating Leases high stood at $99226.0 for Q4 2023, and its period low was $25480.0 during Q3 2023.
  • In the last 4 years, Coeptis Therapeutics Holdings' Operating Leases had a median value of $51065.0 in 2025 and averaged $52572.8.
  • In the last 5 years, Coeptis Therapeutics Holdings' Operating Leases surged by 17892.07% in 2024 and then crashed by 5797.75% in 2025.
  • Quarter analysis of 4 years shows Coeptis Therapeutics Holdings' Operating Leases stood at $56341.0 in 2022, then skyrocketed by 76.12% to $99226.0 in 2023, then crashed by 38.34% to $61180.0 in 2024, then plummeted by 51.19% to $29865.0 in 2025.
  • Its Operating Leases stands at $29865.0 for Q3 2025, versus $40612.0 for Q2 2025 and $51065.0 for Q1 2025.